Top

Published in:

01-02-2013 | Original Communication

A randomized clinical trial of lithium in multiple system atrophy

Authors: Francesco Saccà, Angela Marsili, Mario Quarantelli, Vincenzo Brescia Morra, Arturo Brunetti, Rosa Carbone, Chiara Pane, Giorgia Puorro, Cinzia Valeria Russo, Elena Salvatore, Tecla Tucci, Giuseppe De Michele, Alessandro Filla

Published in: Journal of Neurology | Issue 2/2013

Abstract

The aim of our study was to test the safety and tolerability of lithium in multiple system atrophy (MSA). The study was randomized, placebo-controlled, and double-blind. The primary endpoint of the study was safety and tolerability. An interim analysis, performed 1 year after the first patient was randomized, showed a higher proportion of trial abandon (P < 0.01) and a higher number of adverse events (P < 0.02) in the lithium group. The trial was stopped by the Data Monitoring Committee. Overall, lithium was not well tolerated, and we do not encourage future studies with lithium in MSA patients.

Quinn N (1989) Multiple system atrophy—the nature of the beast. J Neurol Neurosurg Psychiatry (suppl):78–89

Sarkar S, Floto RA, Berger Z et al (2005) Lithium induces autophagy by inhibiting inositol monophosphatase. J Cell Biol 170:1101–1111PubMedCrossRef

Webb JL, Ravikumar B, Atkins J et al (2003) Alpha-synuclein is degraded by both autophagy and the proteasome. J Biol Chem 278:25009–25013PubMedCrossRef

Sarkar S, Krishna G, Imarisio S et al (2008) A rational mechanism for combination treatment of Huntington’s disease using lithium and rapamycin. Hum Mol Genet 17:170–178PubMedCrossRef

Verstraete E, Veldink JH, Huisman MH et al (2012) Lithium lacks effect on survival in amyotrophic lateral sclerosis: a phase IIb randomised sequential trial. J Neurol Neurosurg Psychiatry 83:557–564PubMedCrossRef

Al-Chalabi A, Shaw PJ, Young CA et al (2011) Protocol for a double-blind randomized placebo-controlled trial of lithium carbonate in patients with amyotrophic lateral sclerosis (LiCALS) (Eudract number: 2008-006891-31). BMC Neurol 11:111PubMedCrossRef

Miller RG, Moore DH, Forshew DA et al (2011) Phase II screening trial of lithium carbonate in amyotrophic lateral sclerosis: examining a more efficient trial design. Neurology 77:973–979PubMedCrossRef

Aggarwal SP, Zinman L, Simpson E et al (2010) Safety and efficacy of lithium in combination with riluzole for treatment of amyotrophic lateral sclerosis: a randomised, double-blind, placebo-controlled trial. Lancet Neurol 9:481–488PubMedCrossRef

Forlenza OV, Diniz BS, Radanovic M et al (2011) Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial. Br J Psychiatry 198:351–356PubMedCrossRef

10.

Wenning GK, Tison F, Seppi K et al (2004) Development and validation of the unified multiple system atrophy rating scale (UMSARS). Mov Disord 19:1391–1402PubMedCrossRef

11.

Beck AT, Steer RA, Brown GK et al (1996) BDI-II—beck depression inventory, 2nd edn. The Psychological Corporation Harcourt Brace and Company, San Antonio

12.

Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676PubMedCrossRef

13.

Holmberg B, Johansson JO, Poewe W, Growth-Hormone MSA Study Group; European MSA Study Group et al (2007) Safety and tolerability of growth hormone therapy in multiple system atrophy: a double-blind, placebo-controlled study. Mov Disord 22:1138–1144PubMedCrossRef

14.

Dodel R, Spottke A, Gerhard A et al (2010) Minocycline 1-year therapy in multiple-system-atrophy: effect on clinical symptoms and [(11) C] (R)-PK11195 PET (MEMSA-trial). Mov Disord 25:97–107PubMedCrossRef

Title: A randomized clinical trial of lithium in multiple system atrophy
Authors: Francesco Saccà
Angela Marsili
Mario Quarantelli
Vincenzo Brescia Morra
Arturo Brunetti
Rosa Carbone
Chiara Pane
Giorgia Puorro
Cinzia Valeria Russo
Elena Salvatore
Tecla Tucci
Giuseppe De Michele
Alessandro Filla
Publication date: 01-02-2013
Publisher: Springer-Verlag
Published in: Journal of Neurology / Issue 2/2013
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-012-6655-7

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A randomized clinical trial of lithium in multiple system atrophy

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2013

Valproate as a treatment for dopamine dysregulation syndrome (DDS) in Parkinson’s disease

Acute ataxic neuropathy with hyperreflexia

Generalized tonic–clonic seizures and antiepileptic drugs during pregnancy—a matter of importance for the baby?

Logopenic syndrome in posterior cortical atrophy

Migraine with aura as the predominant phenotype in a family with a PRRT2 mutation

Cognitive and affective theory of mind in patients with essential tremor